MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

One of the most compelling acquisition sagas in the pharma industry in recent times has come to an end, with Pfizer prevailing over Novo Nordisk in a fierce bidding war to acquire ...

The biopharma industry of Europe can use AI to leverage its vast stores of health data to address key challenges.

Alongside their role in mental health, psychedelics are also emerging in neurological and inflammation-driven diseases.

Harbour BioMed and Evinova China have formed a collaboration to implement AI and digital technologies to improve biologics ...

Pelthos Therapeutics has secured the rights to market non-fluorinated quinolone antimicrobial, Xepi (ozenoxacin) Cream, 1% in ...

SanegeneBio has formed a research and licensing partnership with Eli Lilly and Company to develop RNAi candidates for ...

From 18-20 November, Formulated Solutions will be attending the Florida Innovation Conference, held by BioFlorida, at the Walt Disney ...

Though the FDA has requested no new data, the additional information reflects a major amendment to Rhythm’s supplemental new ...

Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...